Should stereotactic radiotherapy be the preferred treatment for oligometastatic disease?

Department of Oncology, Western University, London, ON N6A5W9, Canada (DP); Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, UK (AT) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendationOligometastatic disease has been proposed as an intermediate state between localised and...